SEC Form D · filed July 7, 2016
ZIOPHARM ONCOLOGY INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
John J. Tobin · Seattle, WADirectorBradford G. Jackson · Seattle, WAExecMatthew Zalosh · Boston, MADirectorMichael D. Heffernan · Seattle, WADirectorJames A. Cannon · Boston, MADirectorNancy Spady · Boston, MADirectorWyche Fowler, Jr · Washington, Washington, D.C.DirectorMichael Weiser · Boston, MADirectorSteven Heim · Boston, MAExecEd Braswell · Brentwood, TNExecMurray Brennan · Boston, MADirectorJames D. Mitchell · Seattle, WAExecScott W. Tarriff · Boston, MADirectorBryan J. Weeks · Seattle, WADirectorRandal J. Kirk · Boston, MADirectorKevin G. Lafond · Boston, MAExecArthur N. Budge, Jr · CAMARILLO, CAExecWyche Fowler, Jr · Boston, MADirectorLaurence J. Cooper · Boston, MAExecAli Hamed · New York, NYDirectorFrancois J. Lebel · Boston, MAExecCaesar Belbel · Boston, MAExecFrancois J. Lebel · Boston, MAExecShenkman Capital Management Inc · New York, NYDirectorBill Sasser · Brentwood, TNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗